MD-2 (J-12B) Antibody sc-80183 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemMD-2 (J-12B) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-80183
Antibody TypePrimary Antibodies
NCBI Gene AliasesMD2, MD-2, ESOP-1, ly-96
Quantity100 µg/ml
CloneJ-12B
Reactivityhuman
ApplicationsWB, ELISA
ClonalityMonoclonal
Hostmouse
FormatPurified
Conjugate/TagUnconjugated
NCBI Full Gene Namelymphocyte antigen 96
TargetMD-2
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Harmine alleviates LPS-induced acute lung injury by inhibiting CSF3-mediated MAPK/NF-κB signaling pathwayRespiratory researchMarch 28, 2025Zhai Y, Chen K, Xu Z, Chen X, Tong J, He Y, Chen C, Ding M, Liang G, Zheng X.Cell Signaling Technology (Danvers, MA). Antibodies against TLR4 (Cat. No. sc-293072), MD2 (Cat. No. sc-80183), macrophage markers Ly-6G (Cat. No. sc-53515) and F4/80 (Cat. No. sc-377009) were purchased from Santa Cruz Biotechnology

(2) Cyclic‐di‐GMP induces inflammation and acute lung injury through direct binding to MD2Clinical and Translational MedicineAugust 21, 2024Chenchen Qian, Weiwei Zhu, Jiong Wang, Zhe Wang, Weiyang Tang, Xin Liu, Bo Jin, Yong Xu, Yuyang Zhang, Guang Liang, et al.κB‐α (IκB‐α, 4812S) were from Cell Signaling Technology. Antibodies against TLR4 (sc‐293072), MD2 (sc‐80183), and macrophage markers CD68 (sc‐20060) were purchased from Santa Cruz Biotechnology. Toll/IL‐1R domain‐containing

(3) Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathwayPhytomedicine : international journal of phytotherapy and phytopharmacologyJanuary 1, 2023Ye B, Chen X, Chen Y, Lin W, Xu D, Fang Z, Chattipakorn N, Huang W, Wang X, Wu G, et al.

(4) Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial CellsJournal of immunology (Baltimore, Md. : 1950)October 1, 2022Jin YP, Nevarez-Mejia J, Terry AQ, Sosa RA, Heidt S, Valenzuela NM, Rozengurt E, Reed EF.

(5) Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2Acta pharmacologica SinicaJuly 1, 2022Luo W, Yang LB, Qian CC, Ma B, Manjengwa GM, Miao XM, Wang J, Hu CH, Jin B, Zhang LX, et al.

(6) MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver diseaseClinical and translational medicineMarch 1, 2022Luo W, Ye L, Hu XT, Wang MH, Wang MX, Jin LM, Xiao ZX, Qian JC, Wang Y, Zuo W, et al.lipid accumulation in the liver. 2 MATERIALS AND METHODS 2.1 Reagents Antibodies against MD2 (cat# sc‐80183) and SREBF1 (cat# sc‐365513) were obtained from Santa Cruz Biotechnology (Texas, United States). Antibodies

(7) Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2Phytomedicine : international journal of phytotherapy and phytopharmacologyDecember 1, 2021Yang L, Luo W, Zhang Q, Hong S, Wang Y, Samorodov AV, Chattipakorn N, Pavlov VN, Liang G.

(8) Myeloid differentiation protein 2 mediates angiotensin II-induced inflammation and mesenchymal transition in vascular endotheliumBiochimica et biophysica acta. Molecular basis of diseaseMarch 1, 2021Qian J, Luo W, Dai C, Wang J, Guan X, Zou C, Chattipakorn N, Wu G, Huang W, Liang G.

(9) RP105 plays a cardioprotective role in myocardial ischemia reperfusion injury by regulating the Toll‑like receptor 2/4 signaling pathwaysMolecular medicine reportsAugust 1, 2020Huang W, Yang J, He C, Yang J.protein A beads for 1 h at 4˚C. Afterwards, lysate was incubated with anti‑MD2 antibody (2 µg; cat. no. sc‑80183; Santa Cruz Biotechnology, Inc.) at 4˚C overnight. IgG antibody (1:200; cat. no. sc‑2025; Santa Cruz Biotechnology, Inc

(10) Inhibition of MyD88 by LM8 Attenuates Obesity-Induced Cardiac InjuryJournal of cardiovascular pharmacologyJuly 1, 2020Liu H, Jia W, Tang Y, Zhang W, Qi J, Yan J, Ding W, Cao H, Liang G, Zhu Z, et al.

(11) MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathyNature communicationsMay 1, 2020Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, Chen X, Zhang Y, Wang M, Qian J, et al.

(12) Chaperone insufficiency links TLR4 protein signaling to endoplasmic reticulum stressThe Journal of biological chemistryJanuary 1, 0001"Coope A, Milanski M, Arruda AP, Ignacio-Souza LM, Saad MJ, Anhê GF, Velloso LA."

Be the First to Write a Review!

MD-2 (J-12B) Antibody

MD-2 (J-12B) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (12)

Reviews

MD-2 (J-12B) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map